Provident Company of the Employees of the Hebrew University’s Moderna MRNA Stock Holding History

Provident Company of the Employees of the Hebrew University’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$454K	Hold
2025 Q1	$466K	Buy
2024 Q4	$669K	Sell
2024 Q3	$1.35M	Buy
2024 Q2	$1.54M	Buy
2024 Q1	$1.38M	Buy